XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Series E Preferred Stock
Series E Preferred Stock
Preferred Stock
Series E Preferred Stock
Additional Paid-in Capital
Beginning balance at Dec. 31, 2018 $ (36,525) $ 0 $ 74 $ 546,230 $ (4,877) $ (577,817) $ (135)      
Beginning Balance (shares) at Dec. 31, 2018   0 73,980,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (7,471)         (7,485) 14      
Foreign currency translation adjustment (583)       (583)          
Exercise of stock options and vesting of restricted stock units 399   $ 1 398            
Exercise of stock options and vesting of restricted stock units (shares)     497,000              
Taxes withheld on net settled vesting of restricted stock units (112)     (112)            
Exercise of warrants 10,639   $ 4 10,635            
Exercise of warrants (shares)     4,222,000              
Share-based compensation 1,057     1,057            
Ending balance at Mar. 31, 2019 (32,596) $ 0 $ 79 558,208 (5,460) (585,302) (121)      
Ending Balance (shares) at Mar. 31, 2019   0 78,699,000              
Beginning balance at Dec. 31, 2019 (37,358) $ 0 $ 82 584,862 (3,879) (618,303) (120)      
Beginning Balance (shares) at Dec. 31, 2019   10,000 81,974,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (18,166)         (18,198) 32      
Foreign currency translation adjustment (13,480)       (13,480)          
Exercise of stock options and vesting of restricted stock units 49   $ 0 49            
Exercise of stock options and vesting of restricted stock units (shares)     129,000              
Taxes withheld on net settled vesting of restricted stock units (73)     (73)            
Issuance of shares               $ 27,330   $ 27,330
Issuance of shares (shares)                 27,000  
Issuance of common shares in connection with the Notes Exchange 66,087   $ 14 66,073            
Issuance of common shares in connection with the Notes Exchange (shares)     13,739,000              
Exercise of warrants $ 1,861   $ 0 1,861            
Exercise of warrants (shares) 338,454   338,000              
Share-based compensation $ 1,553     1,553            
Series E preferred stock dividends 0     392   (392)        
Ending balance at Mar. 31, 2020 $ 27,803 $ 0 $ 96 $ 682,047 $ (17,359) $ (636,893) $ (88)      
Ending Balance (shares) at Mar. 31, 2020   37,000 96,180,000